4.6 Review

New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 Vaccination

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

New-onset IgA nephropathy following COVID-19 vaccination

Y. Ma et al.

Summary: The COVID-19 pandemic has caused significant economic and health damage globally, with vaccination being a key strategy to tackle severe illness and death. Recent reports of IgAN following COVID-19 vaccination have raised questions about their relationship. This review summarizes the latest clinical evidence on IgAN post-vaccination and proposes hypotheses for their pathogenesis.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Editorial Material Urology & Nephrology

Membranous nephropathy in a patient with COVID-19 infection

Weiwen Guo et al.

JOURNAL OF NEPHROLOGY (2022)

Letter Urology & Nephrology

Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality?

Anna Psyllaki et al.

CLINICAL KIDNEY JOURNAL (2022)

Article Urology & Nephrology

POS-903 ADVERSE EVENTS FOLLOWING IMMUNISATION (AEFI) OF COVID-19 VACCINES IN KIDNEY PATIENTS- A CASE SERIES

Y. KIG TSUEW et al.

Kidney International Reports (2022)

Article Transplantation

MO208: De Novo Glomerulonephritides Following BNT162B2 COVID-19 Vaccine: A Case Series

Laura Fornara et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Review Medicine, General & Internal

Beyond the lung involvement in COVID-19 patients

Domenico Tuttolomondo et al.

Summary: COVID-19 is a multisystemic and polyhedral disease that can affect not only the upper and lower respiratory tracts, but also other organs, primarily due to the route of viral transmission and specific receptors in certain human organs.

MINERVA MEDICA (2022)

Letter Urology & Nephrology

COVID-19 Vaccination in Patients With Membranous Nephropathy

Ruben Visch et al.

KIDNEY INTERNATIONAL REPORTS (2022)

Letter Medicine, General & Internal

De novo PLA2R positive membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine

Lisa Paxton et al.

INTERNAL MEDICINE JOURNAL (2022)

Article Medicine, General & Internal

A Case of Membranous Nephropathy Hypothesized to be Associated With COVID-19 Vaccine

Wahida Rashid et al.

Summary: A 56-year-old male patient with a medical history of essential hypertension presented with kidney failure and was diagnosed with membranous nephropathy (MN) after developing symptoms of dyspnea and limb swelling. He had a history of a COVID-19-like infection and received the first dose of the Moderna COVID-19 vaccine. Further studies are needed to determine the association between COVID-19 vaccination and the risk of MN, as well as the mechanisms of kidney injury in vaccinated patients.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Article Urology & Nephrology

New Onset Biopsy-Proven Nephropathies after COVID Vaccination

Roberta Fenoglio et al.

Summary: This study analyzed cases of new-onset kidney disease following COVID-19 vaccination. Among the 17 patients, minimal change disease was the most common, followed by acute tubulointerstitial nephritis and membranous nephropathy. Some patients developed acute kidney injury, but renal function recovered after treatment.

AMERICAN JOURNAL OF NEPHROLOGY (2022)

Review Immunology

Review Article Genotype and phenotype of COVID-19: Their roles in pathogenesis

Leila Mousavizadeh et al.

Summary: COVID-19 is a novel coronavirus belonging to the Betacoronavirus genus, with similarities and differences in genomic structure compared to other human Betacoronaviruses. It contains at least six open reading frames and important structural proteins are encoded near the one-third of the genome.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Article Cell Biology

SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions

Purva Asrani et al.

Summary: This paper discusses the rapid spread of the novel coronavirus strain SARS-CoV-2 to different countries and the inflammatory responses induced in the host respiratory system. It emphasizes the importance of researchers finding potential drugs and therapeutic strategies for treating COVID-19, as well as identifying suitable targets within the inflammatory pathways.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Article Urology & Nephrology

Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report

Simon Leclerc et al.

Summary: This case report describes a patient who developed minimal change disease (MCD) and severe acute kidney injury (AKI) following the Oxford-AstraZeneca COVID-19 vaccine. Treatment with glucocorticoids improved kidney function and proteinuria. Further research is needed to determine the association between MCD and COVID-19 vaccination.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Review Immunology

The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease

Ritu Pasrija et al.

Summary: COVID-19 caused by SARS-CoV-2 virus leads to cytokines release syndrome (CRS) in critically ill patients, indicating a deregulated immune response and resulting in inflammation and lung injury in severe cases.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Letter Urology & Nephrology

Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and Proteinuria

Samih H. Nasr et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Article Medicine, Research & Experimental

Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PL A2R1-associated membranous nephropathy

George Haddad et al.

Summary: In primary membranous nephropathy, anti-PLA2R1 IgG4 can induce podocyte injury by activating the lectin pathway. The study results indicate that aberrantly glycosylated IgG4 directly binds to mannose-binding lectin and induces proteolysis of synaptopodin and NEPH1 proteins through two distinct proteolytic pathways.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Chemistry, Multidisciplinary

The dawn of mRNA vaccines: The COVID-19 case

Rein Verbeke et al.

Summary: In less than a year since the COVID-19 pandemic outbreak, mRNA vaccines have made significant progress, with two receiving emergency use authorization and one moving to phase 3 clinical testing. These mRNA vaccines represent a new class of vaccine products, encoding the SARS-CoV-2 Spike glycoprotein to deliver mRNA to cells. The review provides a detailed overview of the composition, clinical performance, and design considerations of the most advanced mRNA vaccines, highlighting new insights and areas for future research and optimization.

JOURNAL OF CONTROLLED RELEASE (2021)

Letter Urology & Nephrology

A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination

Shab E. Gul Rahim et al.

KIDNEY INTERNATIONAL (2021)

Letter Urology & Nephrology

Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination

Mehmet Fethullah Aydin et al.

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

COVID-19 Vaccination and Glomerulonephritis

Nattawat Klomjit et al.

Summary: COVID-19 mRNA vaccine may lead to new or relapsing glomerulonephritis cases.

KIDNEY INTERNATIONAL REPORTS (2021)

Review Immunology

Helper T Cells in Idiopathic Membranous Nephropathy

Qihan Zhao et al.

Summary: Idiopathic membranous nephropathy (IMN) is an autoimmune disease where Th cells, including subsets like Th2, Th17, Tfh, and Treg, play crucial roles in shaping immune imbalance and promoting autoimmune responses. Clinical treatment for IMN should consider targeting Th cells as a key component for effective therapy.

FRONTIERS IN IMMUNOLOGY (2021)

Letter Urology & Nephrology

Membranous nephropathy following anti-COVID-19 mRNA vaccination

Lorraine Gueguen et al.

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)

Rebecca M. May et al.

Summary: This study conducted kidney biopsies on 284 COVID-19 patients in an international collaboration, identifying diseases that have increased in COVID-19 patients and demonstrating a high frequency of high-risk APOL1 genotypes within this group. No direct SARS-CoV-2 viral infection was found within the kidney.

KIDNEY INTERNATIONAL (2021)

Letter Urology & Nephrology

New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination

Maria Fernanda Zavala-Miranda et al.

KIDNEY INTERNATIONAL (2021)

Article Virology

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

Julien Favresse et al.

Summary: Assessing and comparing neutralizing antibodies in COVID-19 patients and vaccinated individuals revealed stronger responses in moderate-severe patients compared to mild patients, while vaccinated individuals had significantly higher NAbs levels than patients.

VIRUSES-BASEL (2021)

Article Urology & Nephrology

Glomerular Disease in Temporal Association with SARS-CoV-2 Vaccination: A Series of 29 Cases

Tiffany N. Caza et al.

Summary: Vaccination against SARS-CoV-2 may trigger kidney diseases in susceptible individuals, but the overall incidence is low and should be closely monitored for as a potential adverse event.

KIDNEY360 (2021)

Article Immunology

Proinflammatory IgG Fc structures in patients with severe COVID-19

Saborni Chakraborty et al.

Summary: COVID-19 is often characterized by a hyperinflammatory syndrome, and disease severity is associated with specific antibody structures that enhance inflammatory responses.

NATURE IMMUNOLOGY (2021)

Article Urology & Nephrology

COVID-19 infection in a membranous nephropathy patient treated with rituximab

Omer Celal Elcioglu et al.

Summary: During the COVID-19 pandemic, striking a balance between combating the outbreak and treating patients with chronic diseases is crucial.

CEN CASE REPORTS (2021)

Article Multidisciplinary Sciences

Cell entry mechanisms of SARS-CoV-2

Jian Shang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Editorial Material Urology & Nephrology

Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic

Andrew M. South et al.

NATURE REVIEWS NEPHROLOGY (2020)

Article Biochemistry & Molecular Biology

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Jonas Schulte-Schrepping et al.

Review Infectious Diseases

The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19

Qing Ye et al.

JOURNAL OF INFECTION (2020)

Article Urology & Nephrology

Kidney Biopsy Findings in Patients with COVID-19

Satoru Kudose et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Biochemistry & Molecular Biology

Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19

Benjamin J. Meckiff et al.

Article Multidisciplinary Sciences

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Ugur Sahin et al.

NATURE (2020)

Review Immunology

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role

Wenbin Liu et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

The Balance of Th17 versus Treg Cells in Autoimmunity

Gap Ryol Lee

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Immunology

Vaccination in the elderly: The challenge of immune changes with aging

Annalisa Ciabattini et al.

SEMINARS IN IMMUNOLOGY (2018)

Editorial Material Urology & Nephrology

Genetic Complexities of the HLA Region and Idiopathic Membranous Nephropathy

Nikol Mladkova et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Article Urology & Nephrology

Primary Membranous Nephropathy

William G. Couser

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Article Biochemistry & Molecular Biology

Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma

James D. Nolin et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)

Article Urology & Nephrology

Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy

Yang Gyun Kim et al.

AMERICAN JOURNAL OF NEPHROLOGY (2015)

Article Urology & Nephrology

Membranous Nephropathy and Severe Acute Kidney Injury Following Influenza Vaccination

Chinmay Patel et al.

SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2015)

Review Urology & Nephrology

Cellular response to injury in membranous nephropathy

M Nangaku et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)

Article Immunology

Immunostimulating capacities of stabilized RNA molecules

B Scheel et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2004)

Article Oncology

Renal ACE2 expression in human kidney disease

AT Lely et al.

JOURNAL OF PATHOLOGY (2004)

Article Cell Biology

Presence of the M-type sPLA2 receptor on neutrophils and its role in elastase release and adhesion

CC Silliman et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)